Wolverine Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Wolverine Asset Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,500	Closed	-$204K	–	1716
2026 Q1	$204K	Buy	+9,500	New	+$134K	﹤0.01%	1081

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wolverine Asset Management's DAWN Position: Q2 2026 in Review

Wolverine Asset Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 9,500 shares — an estimated $204K sold.

Wolverine Asset Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $204K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Wolverine Asset Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Wolverine Asset Management sold 9,500 Day One Biopharmaceuticals shares in Q2 2026, an estimated $204K.
Wolverine Asset Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Wolverine Asset Management's Day One Biopharmaceuticals position peaked at $204K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.